Q1 2023 Catalyst Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to the Catalyst Pharmaceuticals First Quarter 2023 Financial Results Conference Call. (Operator Instructions) As a reminder this conference is being recorded.
It is now my pleasure to introduce your host, Ali Grande, Chief Financial Officer. Thank you, Ali. You may begin.
Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's first quarter 2023 financial results and corporate highlights. Leading the call today is Patrick McEnany, Chairman and Chief Executive Officer. We're also joined by Dr. Steven Miller, our Chief Operating Officer and Chief Scientific Officer; and Jeffrey Del Carmen, our Chief Commercial Officer. Further, for the Q&A session, we'll have Dr. Gary Ingenito, our Chief Medical and Regulatory Officer.
Before we begin, I would like to remind you that in our remarks this morning and in the Q&A session, we will make statements about expected future results which may be forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |